Literature DB >> 12209971

Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.

Tatsuyoshi Funasaka1, Arayo Haga, Avraham Raz, Hisamitsu Nagase.   

Abstract

The autocrine motility factor (AMF) is known as a cytokine regulating tumor cells motility via AMF receptor (AMFR) and promotes their metastasis. Recently, AMFRs have been found on the surface of host cells and it was showed that AMF possibly affects them. The signaling of AMF-AMFR in the host endothelial cells induces expression of a vascular endothelial growth factor receptor (VEGFR) Flt-1 and AMFR feedback that is regulated at the transcriptional level. AMF-exposure stimulated the Flt-1 expression on human umbilical vein endothelial cells (HUVECs) surface and this AMF-treated cells exhibited high-responsibility against VEGF. The protein kinase C (PKC) and phosphatidylinositol 3 kinase (PI3K) play an important role in this signal transduction. The findings of our study suggest the possibility of "tumor AMF-->host AMFR-->PKC, PI3K-->-->VEGFR or AMFR-->angiogenesis, metastasis" as a new signal cross talk between the tumor and the host. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209971     DOI: 10.1002/ijc.10617

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway.

Authors:  Valéry L Payen; Paolo E Porporato; Bjorn Baselet; Pierre Sonveaux
Journal:  Cell Mol Life Sci       Date:  2015-12-01       Impact factor: 9.261

Review 2.  Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis.

Authors:  Demond Williams; Barbara Fingleton
Journal:  Clin Exp Metastasis       Date:  2019-05-09       Impact factor: 5.150

Review 3.  Lactate as an insidious metabolite due to the Warburg effect.

Authors:  Raymond Luc; Stephanie M Tortorella; Katherine Ververis; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

4.  Differential endothelial cell gene expression by African Americans versus Caucasian Americans: a possible contribution to health disparity in vascular disease and cancer.

Authors:  P Wei; L C Milbauer; J Enenstein; J Nguyen; W Pan; R P Hebbel
Journal:  BMC Med       Date:  2011-01-11       Impact factor: 8.775

5.  Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway.

Authors:  Arayo Haga; Tatsuyoshi Funasaka; Yoshihiro Deyashiki; Avraham Raz
Journal:  FEBS Lett       Date:  2008-05-15       Impact factor: 4.124

6.  Intracellular and Extracellular miRNAs in Regulation of Angiogenesis Signaling.

Authors:  Nnenna A Finn; Charles D Searles
Journal:  Curr Angiogenes       Date:  2012-12

7.  Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.

Authors:  Kenichiro Araki; Tatsuo Shimura; Toshiki Yajima; Soichi Tsutsumi; Hideki Suzuki; Kohji Okada; Tsutomu Kobayashi; Avraham Raz; Hiroyuki Kuwano
Journal:  J Biol Chem       Date:  2009-09-30       Impact factor: 5.157

8.  Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.

Authors:  Kosei Nakajima; Takashi Yanagawa; Hideomi Watanabe; Kenji Takagishi
Journal:  Oncol Rep       Date:  2012-10-01       Impact factor: 3.906

9.  Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Ming Zong; Tianbao Lu; Shasha Fan; Hui Zhang; Ruhan Gong; Lishan Sun; Zhiyan Fu; Lieying Fan
Journal:  Arthritis Res Ther       Date:  2015-04-14       Impact factor: 5.156

10.  Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.

Authors:  Liliana D Kojic; Sam M Wiseman; Fariba Ghaidi; Bharat Joshi; Hinyu Nedev; H Uri Saragovi; Ivan R Nabi
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.